Clinical trial
The Effects of Docosahexaenoic Acid (DHA) on Fetal Cardiac Outcomes
NCT01007110 is registered in ClinicalTrials.gov with University of Kansas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Docosahexaenoic Acid (DHA) on Fetal Cardiac Outcomes
- Lead sponsor
- University of Kansas
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- July 31, 2011
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pregnancy